Targeting newly identified ERβ/TGF‐β1/SMAD3 signals with the FDA‐approved anti‐estrogen Faslodex or an ERβ selective antagonist in renal cell carcinoma oleh Wenbin Song, Dalin He, Yule Chen, Chiuan‐Ren Yeh, Iawen Hsu, Qingbo Huang, Xu Zhang, Luke Sien‐Shih Chang, Li Zuo, Jiasheng Chen, Karen M. Doersch, Chawnshang Chang, Lei Li, Shuyuan Yeh